ArticleFrontiers in pharmacology2018

Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia.

Manisha J Oza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.